Prescription Required.Why?
A naturally occurring compound that plays a crucial role in brain cell membrane synthesis and neurotransmitter production.
A nootropic drug known for its potential cognitive-enhancing effects, believed to improve memory and concentration.
Cognitive impairment associated with cerebrovascular disease (stroke)
Agerelated cognitive decline
Traumatic brain injury (TBI)
Neurodegenerative conditions (in some cases, as an adjunct therapy – always consult a physician)
Citicoline boosts the synthesis of phosphatidylcholine, a major component of cell membranes, promoting neuronal membrane integrity and function. Piracetam's mechanism is less clearly understood, but it is thought to modulate neurotransmitter activity, improve cerebral blood flow, and enhance neuronal communication.
Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.
Dosage varies depending on the individual's condition and response to treatment. Always follow your doctor's prescription.
Typically taken orally, with or without food.
Dosage adjustments might be necessary for patients with kidney or liver impairment.
Headache
Dizziness
Drowsiness
Nausea
Diarrhea
Insomnia
Anxiety
Depression (rare)
Avoid excessive alcohol consumption as it can interact negatively with both Citicoline and Piracetam.
Caution is advised, especially when starting treatment, as drowsiness or dizziness are potential side effects.
Use during pregnancy and breastfeeding is generally not recommended unless explicitly prescribed by a doctor due to a lack of sufficient safety data.
Use in children is not typically recommended without explicit medical guidance, as the long term effects are not fully understood.
Patients with kidney impairment may require dosage adjustment, due to potential accumulation of the medication.
Patients with liver impairment may require dosage adjustment, due to potential accumulation of the medication.
Relevant peer-reviewed medical journals (List specific articles if possible)
Pharmaceutical company drug information leaflets (mention specific sources)
